Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
Clinical trial NCT05333003 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05333003
- Sponsor
- Centre for Addiction and Mental Health
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-25
- Primary completion
- 2026-08-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.